Skip to nav Skip to content

News Releases and Statements

Reauthorization of PAHPA Builds Foundation for Public Health Readiness

The reauthorization of the Pandemic and All Hazards Preparedness Act signed by the president Monday includes measures that are critical to ensure that our nation has the resources and expertise needed to confront, control and combat emerging public health threats.

House FY 2020 Appropriations Respond to Most Infectious Disease and HIV Realities

With increased funds for important federal programs and interventions responding to infectious diseases and HIV, the health, foreign operations, and defense spending bill for fiscal year 2020 passed by the House of Representatives Wednesday reflects an understanding of a broad scope of public health threats at home and around the world, and of the resources needed to address them.

Lower Health Care Costs Act Highlights the Value of Vaccines

The Senate Health, Education, Labor and Pensions Committee hearing today on the Lower Health Care Costs Act provides a valuable opportunity for lawmakers to address challenges compromising access to and uptake of vaccines that are among our most important public health tools.

Infectious Diseases Society of America Announces Move to Ballston Quarter

The Infectious Diseases Society of America announced today that it will be relocating its headquarters to 4040 Wilson Boulevard in the Ballston Quarter area of Arlington, Va., a hub of advanced research learning, technology and science in the Washington, D.C. metro area.

Cross-Border Spread of DCR Ebola Outbreak Calls for Immediate, Ongoing Responses

Uganda health officials’ confirmation today of Ebola virus among family members who travelled from the Democratic Republic of Congo brings with it the realization of a concern that has been noted since the August 2018 recognition of the current outbreak.

IDSA Foundation Offers $500,000 in Research Grants to Study Possible Connection

The Infectious Diseases Society of America (IDSA) Foundation, with generous support from Alzheimer’s Germ Quest, Inc. and The Benter Foundation is offering five, one-time $100,000 grants to researchers seeking to identify a potential infectious link to the disease.

HHS Fetal Tissue Research Ban Threatens Progress Toward Cure for HIV, Other Life-threatening Diseases

The Department of Health and Human Services’ decision to halt funding for research involving the use of human fetal tissue conducted within the National Institutes of Health imperils quest for cures of HIV other life-threatening diseases.

DISARM Act Provides Framework Needed to Spur Antibiotic R&D, Protect Existing Drugs

The introduction of the Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms -- DISARM -- Act -- by United States Senators Johnny Isakson (R-GA) and Bob Casey (D-PA) Tuesday represents an essential step toward addressing the growing threat of infections that are increasingly resistant to existing treatments.

Ebola Crisis in DRC Demands Immediate, Ongoing Investments

The Ebola outbreak in the Democratic Republic of Congo’s North Kivu province remains uncontrolled despite heroic efforts on the part of international and local responders. The spread of the disease continues to pose imminent risks of cross-border transmission.

House Spending Bill Recognizes Need to Strengthen Health Responses and Research

Once again rejecting proposed cuts to vital domestic and global health programs and research, House appropriators Wednesday approved funding for fiscal year 2020 that demonstrates commitment to tackling critical health challenges and threats at home and abroad.

Record Measles Numbers Underscore Urgency of Heightened Vaccine Outreach, Access

The announcement by the Centers for Disease Control and Prevention Wednesday that measles cases in the United States have reached numbers unseen since the disease was declared eliminated here in 2000 brings with it the real possibility that measles could again become endemic in this country.

Drug Company Closing Underscores Needs for Swift Federal Action

News today that the antibiotic producer Achaogen has filed for bankruptcy represents the most recent consequence of the steep economic challenges facing antibiotic research and development.

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.